 Kelley Colvin
Concepts (152)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Down Syndrome | 6 | 2024 | 496 | 1.910 |
Why?
| | Respiratory Tract Infections | 2 | 2024 | 390 | 1.240 |
Why?
| | Hypertension, Pulmonary | 11 | 2021 | 1910 | 0.960 |
Why?
| | Myeloid-Derived Suppressor Cells | 1 | 2017 | 66 | 0.500 |
Why?
| | Lymphoid Tissue | 1 | 2013 | 75 | 0.410 |
Why?
| | Blood Vessels | 1 | 2013 | 187 | 0.380 |
Why?
| | Precision Medicine | 1 | 2015 | 429 | 0.340 |
Why?
| | Lung Diseases | 1 | 2017 | 767 | 0.330 |
Why?
| | Proteome | 1 | 2015 | 472 | 0.330 |
Why?
| | Lung | 5 | 2023 | 4060 | 0.330 |
Why?
| | Immunoglobulin G | 1 | 2013 | 893 | 0.310 |
Why?
| | Proteomics | 2 | 2015 | 1111 | 0.300 |
Why?
| | Biomarkers | 2 | 2015 | 4149 | 0.260 |
Why?
| | Autoantibodies | 1 | 2013 | 1496 | 0.240 |
Why?
| | Cardiovascular Diseases | 1 | 2017 | 2111 | 0.220 |
Why?
| | Disease Models, Animal | 4 | 2023 | 4295 | 0.190 |
Why?
| | Biology | 1 | 2023 | 88 | 0.190 |
Why?
| | Interferons | 1 | 2024 | 202 | 0.190 |
Why?
| | Leukocytes | 1 | 2024 | 311 | 0.190 |
Why?
| | Tissue Inhibitor of Metalloproteinases | 1 | 2021 | 19 | 0.180 |
Why?
| | Ventricular Function | 1 | 2021 | 61 | 0.180 |
Why?
| | Matrix Metalloproteinases | 1 | 2021 | 95 | 0.170 |
Why?
| | Cytokines | 4 | 2017 | 2085 | 0.160 |
Why?
| | Pulmonary Artery | 4 | 2021 | 1086 | 0.160 |
Why?
| | Gene Expression | 2 | 2024 | 1502 | 0.160 |
Why?
| | Interferon-alpha | 1 | 2019 | 198 | 0.150 |
Why?
| | Prognosis | 2 | 2017 | 4030 | 0.140 |
Why?
| | Fibroblasts | 2 | 2013 | 996 | 0.130 |
Why?
| | Intercellular Signaling Peptides and Proteins | 2 | 2012 | 382 | 0.130 |
Why?
| | TRPM Cation Channels | 1 | 2017 | 74 | 0.130 |
Why?
| | Vascular Stiffness | 1 | 2021 | 494 | 0.120 |
Why?
| | Cardiovascular System | 1 | 2017 | 137 | 0.120 |
Why?
| | Cause of Death | 1 | 2017 | 434 | 0.110 |
Why?
| | Receptor, Endothelin B | 4 | 2012 | 51 | 0.110 |
Why?
| | Humans | 12 | 2024 | 137585 | 0.100 |
Why?
| | Receptors, Endothelin | 2 | 2003 | 51 | 0.100 |
Why?
| | Rats, Wistar | 1 | 2013 | 455 | 0.100 |
Why?
| | Child | 7 | 2024 | 21935 | 0.090 |
Why?
| | Bronchi | 1 | 2013 | 260 | 0.090 |
Why?
| | Endothelin-1 | 2 | 2012 | 182 | 0.090 |
Why?
| | Arteritis | 1 | 2012 | 28 | 0.090 |
Why?
| | Unfolded Protein Response | 1 | 2012 | 59 | 0.090 |
Why?
| | Rats | 5 | 2013 | 5647 | 0.090 |
Why?
| | Case-Control Studies | 2 | 2017 | 3556 | 0.090 |
Why?
| | Muscle, Smooth, Vascular | 2 | 2012 | 446 | 0.090 |
Why?
| | Animals | 7 | 2023 | 36940 | 0.090 |
Why?
| | Inflammation | 4 | 2017 | 2837 | 0.090 |
Why?
| | Phagocytes | 1 | 2011 | 101 | 0.080 |
Why?
| | Inflammation Mediators | 1 | 2013 | 513 | 0.080 |
Why?
| | Mesoderm | 1 | 2011 | 144 | 0.080 |
Why?
| | Myeloid Cells | 1 | 2011 | 148 | 0.080 |
Why?
| | Blood Proteins | 1 | 2012 | 252 | 0.080 |
Why?
| | Dendritic Cells | 1 | 2013 | 483 | 0.080 |
Why?
| | Male | 10 | 2023 | 67762 | 0.080 |
Why?
| | Myocytes, Smooth Muscle | 1 | 2012 | 261 | 0.080 |
Why?
| | Heart Defects, Congenital | 1 | 2017 | 842 | 0.080 |
Why?
| | Mice | 2 | 2023 | 17787 | 0.070 |
Why?
| | Phenotype | 1 | 2017 | 3196 | 0.070 |
Why?
| | Genetic Predisposition to Disease | 1 | 2017 | 2426 | 0.070 |
Why?
| | Autoimmunity | 1 | 2013 | 908 | 0.070 |
Why?
| | Flow Cytometry | 3 | 2019 | 1178 | 0.060 |
Why?
| | Gene Expression Profiling | 1 | 2013 | 1774 | 0.060 |
Why?
| | Female | 9 | 2023 | 73304 | 0.060 |
Why?
| | Tunica Intima | 1 | 2005 | 84 | 0.060 |
Why?
| | Arterial Occlusive Diseases | 1 | 2005 | 83 | 0.060 |
Why?
| | Endothelial Growth Factors | 1 | 2003 | 64 | 0.050 |
Why?
| | Lymphokines | 1 | 2003 | 131 | 0.050 |
Why?
| | Pulmonary Edema | 1 | 2003 | 108 | 0.050 |
Why?
| | Risk Factors | 1 | 2017 | 10388 | 0.050 |
Why?
| | Chemokine CCL2 | 2 | 2012 | 115 | 0.050 |
Why?
| | Arterial Pressure | 1 | 2021 | 126 | 0.040 |
Why?
| | Animals, Genetically Modified | 3 | 2005 | 240 | 0.040 |
Why?
| | Hypoxia | 2 | 2003 | 1112 | 0.040 |
Why?
| | Receptor, Endothelin A | 2 | 2012 | 65 | 0.040 |
Why?
| | Adolescent | 5 | 2021 | 21513 | 0.040 |
Why?
| | Listeriosis | 1 | 2017 | 70 | 0.030 |
Why?
| | Listeria monocytogenes | 1 | 2017 | 126 | 0.030 |
Why?
| | Hemodynamics | 1 | 2021 | 1113 | 0.030 |
Why?
| | Vascular Endothelial Growth Factor A | 2 | 2012 | 545 | 0.030 |
Why?
| | Hypertension | 1 | 2005 | 1295 | 0.030 |
Why?
| | Atrial Natriuretic Factor | 1 | 2015 | 57 | 0.030 |
Why?
| | Breath Tests | 1 | 2015 | 87 | 0.030 |
Why?
| | Natriuretic Peptide, Brain | 1 | 2015 | 99 | 0.030 |
Why?
| | Reactive Oxygen Species | 1 | 2017 | 622 | 0.030 |
Why?
| | Cell-Derived Microparticles | 1 | 2015 | 71 | 0.030 |
Why?
| | Infant | 3 | 2012 | 9465 | 0.030 |
Why?
| | Vascular Remodeling | 1 | 2015 | 193 | 0.030 |
Why?
| | Child, Preschool | 3 | 2012 | 11074 | 0.030 |
Why?
| | Endothelins | 2 | 2003 | 65 | 0.020 |
Why?
| | Regulatory Factor X Transcription Factors | 1 | 2012 | 11 | 0.020 |
Why?
| | Activating Transcription Factor 6 | 1 | 2012 | 20 | 0.020 |
Why?
| | Echocardiography | 1 | 2015 | 642 | 0.020 |
Why?
| | Endothelin A Receptor Antagonists | 1 | 2012 | 26 | 0.020 |
Why?
| | Immunity, Innate | 1 | 2017 | 828 | 0.020 |
Why?
| | Mitogen-Activated Protein Kinase 3 | 1 | 2012 | 152 | 0.020 |
Why?
| | Leukocyte Common Antigens | 1 | 2011 | 87 | 0.020 |
Why?
| | Chemokine CXCL12 | 1 | 2011 | 81 | 0.020 |
Why?
| | Peptide Fragments | 1 | 2015 | 706 | 0.020 |
Why?
| | Mitogen-Activated Protein Kinase 1 | 1 | 2012 | 185 | 0.020 |
Why?
| | Cell Count | 1 | 2011 | 324 | 0.020 |
Why?
| | Interleukin-10 | 1 | 2012 | 302 | 0.020 |
Why?
| | Immunomodulation | 1 | 2011 | 98 | 0.020 |
Why?
| | Fluorescent Antibody Technique | 1 | 2011 | 390 | 0.020 |
Why?
| | Mice, Knockout | 1 | 2017 | 3015 | 0.020 |
Why?
| | Vasodilator Agents | 1 | 2012 | 331 | 0.020 |
Why?
| | Cell Separation | 1 | 2011 | 318 | 0.020 |
Why?
| | Transcription Factors | 2 | 2012 | 1719 | 0.020 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 1 | 2012 | 852 | 0.020 |
Why?
| | Hyaluronic Acid | 1 | 2012 | 225 | 0.020 |
Why?
| | Endothelial Cells | 1 | 2015 | 785 | 0.020 |
Why?
| | Arrhythmias, Cardiac | 1 | 2011 | 333 | 0.020 |
Why?
| | Monocytes | 1 | 2012 | 563 | 0.020 |
Why?
| | MicroRNAs | 1 | 2015 | 692 | 0.020 |
Why?
| | Polymerase Chain Reaction | 1 | 2011 | 1062 | 0.020 |
Why?
| | Interleukin-6 | 1 | 2012 | 778 | 0.020 |
Why?
| | Cardiac Catheterization | 1 | 2011 | 530 | 0.020 |
Why?
| | Adult | 3 | 2019 | 37929 | 0.020 |
Why?
| | Phosphorylation | 1 | 2012 | 1759 | 0.020 |
Why?
| | Stem Cells | 1 | 2011 | 594 | 0.020 |
Why?
| | Mice, Inbred C57BL | 1 | 2017 | 5757 | 0.020 |
Why?
| | Monocrotaline | 1 | 2005 | 28 | 0.010 |
Why?
| | Tomography, X-Ray Computed | 1 | 2015 | 2691 | 0.010 |
Why?
| | Young Adult | 2 | 2011 | 13209 | 0.010 |
Why?
| | Hypertrophy, Right Ventricular | 1 | 2005 | 145 | 0.010 |
Why?
| | DNA-Binding Proteins | 1 | 2012 | 1502 | 0.010 |
Why?
| | Rats, Mutant Strains | 1 | 2003 | 25 | 0.010 |
Why?
| | Vascular Endothelial Growth Factors | 1 | 2003 | 79 | 0.010 |
Why?
| | Endothelin Receptor Antagonists | 1 | 2003 | 62 | 0.010 |
Why?
| | Isoxazoles | 1 | 2003 | 54 | 0.010 |
Why?
| | Capillary Permeability | 1 | 2003 | 145 | 0.010 |
Why?
| | Magnetic Resonance Imaging | 1 | 2015 | 3566 | 0.010 |
Why?
| | Thiophenes | 1 | 2003 | 117 | 0.010 |
Why?
| | 6-Ketoprostaglandin F1 alpha | 1 | 2002 | 21 | 0.010 |
Why?
| | Blotting, Northern | 1 | 2002 | 201 | 0.010 |
Why?
| | Intramolecular Oxidoreductases | 1 | 2002 | 68 | 0.010 |
Why?
| | In Situ Hybridization | 1 | 2002 | 316 | 0.010 |
Why?
| | Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2003 | 278 | 0.010 |
Why?
| | Disease Susceptibility | 1 | 2003 | 347 | 0.010 |
Why?
| | Cytochrome P-450 Enzyme System | 1 | 2002 | 155 | 0.010 |
Why?
| | Protein Precursors | 1 | 2002 | 134 | 0.010 |
Why?
| | Epoprostenol | 1 | 2002 | 136 | 0.010 |
Why?
| | Nitric Oxide Synthase | 1 | 2002 | 240 | 0.010 |
Why?
| | Nitric Oxide Synthase Type III | 1 | 2002 | 204 | 0.010 |
Why?
| | Infant, Newborn | 1 | 2012 | 6079 | 0.010 |
Why?
| | Blotting, Western | 1 | 2003 | 1226 | 0.010 |
Why?
| | Pulmonary Circulation | 1 | 2002 | 429 | 0.010 |
Why?
| | Signal Transduction | 1 | 2012 | 5079 | 0.010 |
Why?
| | Middle Aged | 1 | 2019 | 33479 | 0.010 |
Why?
| | Cell Proliferation | 1 | 2005 | 2475 | 0.010 |
Why?
| | Treatment Outcome | 1 | 2012 | 10811 | 0.010 |
Why?
| | Nitric Oxide | 1 | 2002 | 915 | 0.010 |
Why?
| | RNA, Messenger | 1 | 2002 | 2833 | 0.010 |
Why?
|
|
Colvin's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|